Fernando Bril1, Diana Barb1, Paola Portillo-Sanchez1, Diane Biernacki1, Romina Lomonaco1, Amitabh Suman2, Michelle H Weber3, Jeffrey T Budd4, Maria E Lupi5, Kenneth Cusi1,6. 1. Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL. 2. Division of Gastroenterology, Hepatology and Nutrition, Malcom Randall VAMC, Gainesville, FL. 3. Department of Pathology, Malcom Randall VAMC, Gainesville, FL. 4. Department of Medicine, University of Florida, Gainesville, FL. 5. Division of Family Medicine, University of Florida, Gainesville, FL. 6. Division of Endocrinology, Diabetes and Metabolism, Malcom Randall VAMC, Gainesville, FL.
Abstract
The cut-off point of intrahepatic triglyceride (IHTG) content to define nonalcoholic fatty liver disease (NAFLD) by proton magnetic resonance spectroscopy (1 H-MRS) was established based on the 95th percentile in a group of healthy individuals (i.e., ≥5.56%). Whether this threshold correlates with metabolic and histological changes and whether a further accumulation of IHTG is associated with worsening of these parameters has not been properly assessed in a large cohort of patients. In this cross-sectional study, 352 subjects were carefully characterized with the following studies: liver 1 H-MRS; euglycemic insulin clamp with measurement of glucose turnover; oral glucose tolerance test; and a liver biopsy. Hepatic insulin sensitivity (suppression of endogenous glucose production by insulin) was affected early on after IHTG content was ∼1.5% and remained uniformly impaired (∼40%-45%), regardless of further IHTG accumulation. Skeletal muscle insulin sensitivity showed a gradual impairment at low degrees of IHTG accumulation, but remained unchanged after IHTG content reached the ∼6 ± 2% threshold. A similar pattern was observed for metabolic changes typically associated with NAFLD, such as hypertriglyceridemia and low high-density lipoprotein cholesterol (HDL-C). In contrast, adipose tissue insulin sensitivity (suppression of free fatty acids by insulin) showed a continuous worsening across the spectrum of IHTG accumulation in NAFLD (r = -0.38; P < 0.001). Histological severity of liver disease (inflammation, ballooning, and fibrosis) was not associated with the amount of IHTG content. CONCLUSION: IHTG accumulation is strongly associated with adipose tissue insulin resistance (IR), supporting the current theory of lipotoxicity as a driver of IHTG accumulation. Once IHTG accumulation reaches ∼6 ± 2%, skeletal muscle IR, hypertriglyceridemia, and low HDL-C become fully established. Histological activity appears to have an early threshold and is not significantly influenced by increasing amounts of IHTG accumulation. (Hepatology 2017;65:1132-1144).
The cut-off point of intrahepatic triglyceride (IHTG) content to define nonalcoholic fatty liver disease (NAFLD) by proton magnetic resonance spectroscopy (1 H-MRS) was established based on the 95th percentile in a group of healthy individuals (i.e., ≥5.56%). Whether this threshold correlates with metabolic and histological changes and whether a further accumulation of IHTG is associated with worsening of these parameters has not been properly assessed in a large cohort of patients. In this cross-sectional study, 352 subjects were carefully characterized with the following studies: liver 1 H-MRS; euglycemic insulin clamp with measurement of glucose turnover; oral glucose tolerance test; and a liver biopsy. Hepatic insulin sensitivity (suppression of endogenous glucose production by insulin) was affected early on after IHTG content was ∼1.5% and remained uniformly impaired (∼40%-45%), regardless of further IHTG accumulation. Skeletal muscle insulin sensitivity showed a gradual impairment at low degrees of IHTG accumulation, but remained unchanged after IHTG content reached the ∼6 ± 2% threshold. A similar pattern was observed for metabolic changes typically associated with NAFLD, such as hypertriglyceridemia and low high-density lipoprotein cholesterol (HDL-C). In contrast, adipose tissue insulin sensitivity (suppression of free fatty acids by insulin) showed a continuous worsening across the spectrum of IHTG accumulation in NAFLD (r = -0.38; P < 0.001). Histological severity of liver disease (inflammation, ballooning, and fibrosis) was not associated with the amount of IHTG content. CONCLUSION:IHTG accumulation is strongly associated with adipose tissue insulin resistance (IR), supporting the current theory of lipotoxicity as a driver of IHTG accumulation. Once IHTG accumulation reaches ∼6 ± 2%, skeletal muscle IR, hypertriglyceridemia, and low HDL-C become fully established. Histological activity appears to have an early threshold and is not significantly influenced by increasing amounts of IHTG accumulation. (Hepatology 2017;65:1132-1144).
Authors: Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi Journal: Eur Respir J Date: 2020-04-09 Impact factor: 16.671
Authors: Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Arun J Sanyal; Brent A Neuschwander-Tetri Journal: Hepatology Date: 2019-03-07 Impact factor: 17.425
Authors: Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke Journal: Nat Rev Gastroenterol Hepatol Date: 2020-10-22 Impact factor: 46.802
Authors: Yuval A Patel; Elizabeth J Gifford; Lisa M Glass; Marsha J Turner; Byungjoo Han; Cynthia A Moylan; Steve Choi; Ayako Suzuki; Dawn Provenzale; Christine M Hunt Journal: Dig Dis Sci Date: 2018-05-19 Impact factor: 3.199
Authors: Gordon I Smith; David C Polidori; Mihoko Yoshino; Monica L Kearney; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein Journal: J Clin Invest Date: 2020-06-01 Impact factor: 14.808
Authors: Jack A Sargeant; Stephen Bawden; Guruprasad P Aithal; Elizabeth J Simpson; Ian A Macdonald; Mark C Turner; Jessica Cegielski; Kenneth Smith; James L Dorling; Penny A Gowland; Myra A Nimmo; James A King Journal: Eur J Appl Physiol Date: 2018-02-06 Impact factor: 3.078